DANAHER CORPORATION

Lobbying for DANAHER CORPORATION · health care products developer and manufacturer

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$230,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 5

Food & Drug Administration (FDA)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.